These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21436768)

  • 41. Patients with low compared with high body mass index gain more weight after implantation of a continuous-flow left ventricular assist device.
    Emani S; Brewer RJ; John R; Slaughter MS; Lanfear DE; Ravi Y; Sundareswaran KS; Farrar DJ; Sai-Sudhakar CB
    J Heart Lung Transplant; 2013 Jan; 32(1):31-5. PubMed ID: 23164534
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes.
    Baumwol J; Macdonald PS; Keogh AM; Kotlyar E; Spratt P; Jansz P; Hayward CS
    J Heart Lung Transplant; 2011 Aug; 30(8):888-95. PubMed ID: 21530314
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Obese patients and mechanical circulatory support: weight loss, adverse events, and outcomes.
    Zahr F; Genovese E; Mathier M; Shullo M; Lockard K; Zomak R; McNamara D; Toyoda Y; Kormos RL; Teuteberg JJ
    Ann Thorac Surg; 2011 Oct; 92(4):1420-6. PubMed ID: 21958791
    [TBL] [Abstract][Full Text] [Related]  

  • 44. End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices.
    Radovancevic B; Vrtovec B; de Kort E; Radovancevic R; Gregoric ID; Frazier OH
    J Heart Lung Transplant; 2007 Aug; 26(8):815-8. PubMed ID: 17692785
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial.
    Rogers JG; Butler J; Lansman SL; Gass A; Portner PM; Pasque MK; Pierson RN;
    J Am Coll Cardiol; 2007 Aug; 50(8):741-7. PubMed ID: 17707178
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Should patients 60 years and older undergo bridge to transplantation with continuous-flow left ventricular assist devices?
    Allen JG; Kilic A; Weiss ES; Arnaoutakis GJ; George TJ; Shah AS; Conte JV
    Ann Thorac Surg; 2012 Dec; 94(6):2017-24. PubMed ID: 22858277
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcome of unplanned right ventricular assist device support for severe right heart failure after implantable left ventricular assist device insertion.
    Takeda K; Naka Y; Yang JA; Uriel N; Colombo PC; Jorde UP; Takayama H
    J Heart Lung Transplant; 2014 Feb; 33(2):141-8. PubMed ID: 23932442
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prior Sternotomy and Ventricular Assist Device Implantation Do Not Adversely Impact Survival or Allograft Function After Heart Transplantation.
    Gaffey AC; Phillips EC; Howard J; Hung G; Han J; Emery R; Goldberg L; Acker MA; Woo YJ; Atluri P
    Ann Thorac Surg; 2015 Aug; 100(2):542-9. PubMed ID: 26070597
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Durable left ventricular assist device implantation in extremely obese heart failure patients.
    Lee AY; Tecson KM; Lima B; Shaikh AF; Collier J; Still S; Baxter R; DiMaio JM; Felius J; Carey SA; Gonzalez-Stawinski GV; Nauret R; Wong M; Hall SA; Joseph SM
    Artif Organs; 2019 Mar; 43(3):234-241. PubMed ID: 30357882
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ventricular assist device application as a bridge to pediatric heart transplantation: a single center's experience.
    Hsu KH; Huang SC; Chou NH; Chi NH; Tsao CI; Ko WJ; Chen YS; Chang CI; Chiu IS; Wang SS
    Transplant Proc; 2012 May; 44(4):883-5. PubMed ID: 22564574
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of centrifugal left ventricular assist device as a bridge to candidacy in severe heart failure with secondary pulmonary hypertension.
    Kutty RS; Parameshwar J; Lewis C; Catarino PA; Sudarshan CD; Jenkins DP; Dunning JJ; Tsui SS
    Eur J Cardiothorac Surg; 2013 Jun; 43(6):1237-42. PubMed ID: 23345184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Left ventricular assist device destination therapy versus extended criteria cardiac transplant.
    Daneshmand MA; Rajagopal K; Lima B; Khorram N; Blue LJ; Lodge AJ; Hernandez AF; Rogers JG; Milano CA
    Ann Thorac Surg; 2010 Apr; 89(4):1205-9; discussion 1210. PubMed ID: 20338335
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of pulsatile and non-pulsatile left ventricular assist devices on the renin-angiotensin system in patients with end-stage heart failure.
    Welp H; Rukosujew A; Tjan TD; Hoffmeier A; Kösek V; Scheld HH; Drees G
    Thorac Cardiovasc Surg; 2010 Feb; 58 Suppl 2():S185-8. PubMed ID: 20101537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. How does successful bridging with ventricular assist device affect cardiac transplantation outcome?
    Urban M; Pirk J; Dorazilova Z; Netuka I
    Interact Cardiovasc Thorac Surg; 2011 Oct; 13(4):405-9. PubMed ID: 21788304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of Body Mass Index on Outcomes in Left Ventricular Assist Device Recipients.
    Go PH; Nemeh HW; Borgi J; Paone G; Morgan JA
    J Card Surg; 2016 Apr; 31(4):242-7. PubMed ID: 26856974
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiac transplantation is still the method of choice in the treatment of patients with severe heart failure.
    Korewicki J
    Cardiol J; 2009; 16(6):493-9. PubMed ID: 19950084
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Impact of Obesity on Left Ventricular Assist Device Outcomes.
    Zhigalov K; Sá MPBO; Arjomandi Rad A; Vardanyan R; Goerdt L; Chrosch T; Zubarevich A; Wendt D; Pizanis N; Koch A; Kamler M; Berger R; Schmack B; Ruhparwar A; Popov AF; Weymann A
    Medicina (Kaunas); 2020 Oct; 56(11):. PubMed ID: 33113962
    [No Abstract]   [Full Text] [Related]  

  • 59. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
    Liden H; Haraldsson A; Ricksten SE; Kjellman U; Wiklund L
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Effect of Left Ventricular Assist Device Implantation on Serum Albumin, Total Protein and Body Mass: A Short-Term, Longitudinal Follow-Up Study.
    Guvenc TS; Güzelburc O; Ekmekci A; Erdogan SB; Guvenc RC; Velibey Y; Tasdemir M; Agustos S; Orhan G; Aka SA; Eren M
    Heart Lung Circ; 2017 Jul; 26(7):702-708. PubMed ID: 27939745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.